Program coordinator Sarah Solar is the nexus point for the UC Davis Institute for Psychedelics and Neurotherapeutics. They liaison between campuses, establish connections between faculty affiliates and the institute, track funding, and coordinate and manage communications, among a host of other tasks. Their fingers are on the institute’s pulse, ensuring its operational functionality.

Annaliese Franz and her lab are designing therapeutic molecules of the future. Through organic synthesis and catalysis, the team is building and improving molecules with therapeutic potential. Some current projects include developing a new nanoparticle technology for livestock vaccines and improving treatments for neurodegenerative disorders like epilepsy. 

UC Davis researchers unveil CaST, a tool that rapidly tags neurons affected by psychedelics, offering insights into therapeutic mechanisms.